| abstract |
Benzomorpholine derivatives typified by compounds represented by the following general formula (VIII), pharmaceutically acceptable salts thereof and platelet aggregation inhibitors comprising the same. Because of having a potent effect of inhibiting platelet aggregation, these compounds are efficacious in treating and preventing diseases to which thrombi relate. (VIII) |